Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: September 28, 2022 12:52


Allogene Therapeutics stock price online today

Analyst Target Price

27.13

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Allogene Therapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2022, 2023, 2024?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $27.13 target price for Allogene Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (11.4 $).

50 Day Moving Average is the resistance level (14.19 $).




Allogene Therapeutics stock monthly Forecast

Date Rate Forecast MIN Rate MAX Rate Volati-
lity, %
30 Sep 22 11.74 11.44 12.07 5.53 %
01 Oct 22 11.60 11.27 12.24 8.65 %
02 Oct 22 11.53 11.23 11.74 4.53 %
03 Oct 22 10.95 10.68 11.54 8.11 %
04 Oct 22 10.90 10.74 11.22 4.48 %
05 Oct 22 11.35 11.17 11.86 6.19 %
06 Oct 22 11.10 10.51 11.50 9.38 %
07 Oct 22 11.11 10.54 11.62 10.25 %
08 Oct 22 11.31 10.79 11.93 10.57 %
09 Oct 22 11.64 11.44 11.87 3.77 %
10 Oct 22 11.31 11.04 11.83 7.25 %
11 Oct 22 11.66 11.47 12.16 5.98 %
12 Oct 22 11.63 11.24 12.28 9.27 %
13 Oct 22 11.60 11.20 11.83 5.65 %
14 Oct 22 11.97 11.54 12.60 9.15 %
15 Oct 22 11.61 11.21 11.80 5.29 %
16 Oct 22 11.74 11.43 12.15 6.25 %
17 Oct 22 11.72 11.25 11.95 6.27 %
18 Oct 22 11.42 11.04 11.67 5.65 %
19 Oct 22 11.64 11.19 12.23 9.25 %
20 Oct 22 11.57 11.04 12.18 10.27 %
21 Oct 22 11.51 11.13 11.86 6.51 %
22 Oct 22 12.12 11.68 12.40 6.10 %
23 Oct 22 12.21 11.90 12.67 6.46 %
24 Oct 22 11.97 11.43 12.41 8.50 %
25 Oct 22 11.64 11.38 11.91 4.65 %
26 Oct 22 11.17 10.74 11.75 9.39 %
27 Oct 22 11.27 10.87 11.87 9.22 %
28 Oct 22 11.50 11.28 11.81 4.71 %
29 Oct 22 11.78 11.59 12.44 7.26 %

ALLO daily forecast for this month


Allogene Therapeutics stock forecast for 30.09.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.74 Positive intraday dynamics of the instrument is expected with 5.244% volatility is expected.

Pessimistic forecast: 11.44

Optimistic: 12.07


Allogene Therapeutics stock forecast for 01.10.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.60 Negative intraday dynamics of the instrument is expected with 7.959% volatility is expected.

Pessimistic forecast: 11.27

Optimistic: 12.24


Allogene Therapeutics stock forecast for 02.10.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.53 Negative intraday dynamics of the instrument is expected with 4.331% volatility is expected.

Pessimistic forecast: 11.23

Optimistic: 11.74


Allogene Therapeutics stock forecast for 03.10.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 10.95 Negative intraday dynamics of the instrument is expected with 7.505% volatility is expected.

Pessimistic forecast: 10.68

Optimistic: 11.54


Allogene Therapeutics stock forecast for 04.10.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 10.90 Negative intraday dynamics of the instrument is expected with 4.284% volatility is expected.

Pessimistic forecast: 10.74

Optimistic: 11.22


ALLO Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Oct 10.25 10.02 10.89 8.00 %
Nov 10.56 10.34 10.89 5.04 %
Dec 11.05 10.31 11.42 9.68 %

Allogene Therapeutics stock forecast for this year


Allogene Therapeutics share price average forecast for Oct 2022 is: 10.2483 The dynamics are negative.
Allogene Therapeutics share price average forecast for Nov 2022 is: 10.5557 The dynamics are positive.
Allogene Therapeutics share price average forecast for Dec 2022 is: 11.0519 The dynamics are positive.


Allogene Therapeutics stock Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 10.62 10.21 11.40 10.44 %
Feb 9.71 8.95 10.35 13.51 %
Mar 9.31 8.98 9.55 5.95 %
Apr 9.72 9.49 10.36 8.44 %
May 9.25 8.70 9.84 11.57 %
Jun 8.87 8.42 9.27 9.19 %
Jul 8.13 7.76 8.62 9.99 %
Aug 8.27 7.70 8.50 9.44 %
Sep 8.18 7.74 8.77 11.75 %
Oct 8.20 8.00 8.69 7.92 %
Nov 8.09 7.86 8.48 7.35 %
Dec 7.94 7.69 8.35 7.89 %

Allogene Therapeutics stock Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 7.79 7.49 8.06 7.05 %
Feb 7.67 7.39 8.25 10.50 %
Mar 7.41 7.15 7.66 6.58 %
Apr 7.43 7.02 7.83 10.33 %
May 6.99 6.48 7.51 13.77 %
Jun 6.73 6.45 7.19 10.30 %
Jul 6.82 6.48 7.34 11.70 %
Aug 6.41 5.92 6.54 9.51 %
Sep 6.33 6.00 6.57 8.58 %
Oct 6.69 6.48 7.09 8.50 %
Nov 6.64 6.45 6.88 6.27 %
Dec 6.60 6.10 6.95 12.24 %



Allogene Therapeutics stock Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 6.26 5.88 6.67 11.90 %
Feb 6.17 5.79 6.37 9.01 %
Mar 5.90 5.52 6.20 11.04 %
Apr 5.97 5.84 6.18 5.50 %
May 5.91 5.66 6.11 7.36 %
Jun 5.65 5.50 5.99 8.22 %
Jul 5.56 5.40 5.81 7.07 %
Aug 5.74 5.59 6.14 8.96 %
Sep 6.19 6.02 6.68 9.91 %
Oct 6.43 6.16 6.67 7.71 %
Nov 7.05 6.79 7.50 9.49 %
Dec 7.54 7.11 7.80 8.80 %

Allogene Therapeutics stock Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 7.73 7.11 8.00 11.11 %
Feb 7.16 6.78 7.55 10.15 %
Mar 7.47 7.11 7.65 7.13 %
Apr 7.23 6.80 7.61 10.65 %
May 7.67 7.20 8.04 10.40 %
Jun 8.27 7.74 8.53 9.30 %
Jul 7.97 7.53 8.38 10.17 %
Aug 8.60 8.34 9.20 9.35 %
Sep 9.36 8.70 9.84 11.61 %
Oct 9.02 8.79 9.38 6.25 %
Nov 9.86 9.16 10.07 9.01 %
Dec 9.50 8.81 9.84 10.42 %

Allogene Therapeutics overview

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

1 527 230 000 $

EBITDA

-294 208 992

PE Ratio

None

PEG Ratio

None

Dividend Per Share

0

Dividend Yield

0

EPS

-2.2

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.955

Trailing PE

-

Forward PE

-

EV To Revenue

4595.01

EV To EBITDA

-3.858

52 Week High

26.21

52 Week Low

6.43

50 Day Moving Average

14.19

200 Day Moving Average

11.4

Shares Outstanding

143807000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 98.72 (28.09.2022) 0.40 %
AbbVie Inc.
ABBV 144.6 (28.09.2022) 2.03 %
Aeterna Zentaris Inc.
AEZS 3.8 (27.09.2022) 2.98 %
Allakos Inc.
ALLK 5.16 (27.09.2022) -7.86 %
Allogene Therapeutics, Inc.
ALLO 11.26 (27.09.2022) 3.49 %
Amgen Inc.
AMGN 225.99 (27.09.2022) -0.39 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 3.33 (27.09.2022) -1.77 %
Aurora Cannabis Inc.
ACB 1.21 (27.09.2022) 4.31 %
Becton Dickinson and Company
BDX 228.34 (27.09.2022) -1.42 %
Biogen Inc.
BIIB 276.61 (28.09.2022) 39.85 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 152.2 (27.09.2022) 0.15 %
BioNTech SE
BNTX 133.79 (28.09.2022) 2.68 %
bluebird bio, Inc.
BLUE 5.45 (27.09.2022) 5.62 %
Boston Scientific Corp.
BSX 38.36 (26.09.2022) -1.39 %
Bristol-Myers Squibb Company
BMY 72.06 (28.09.2022) 2.42 %
Canopy Growth Corp.
CGC 2.86 (27.09.2022) 4.38 %
Castle Biosciences, Inc.
CSTL 23.78 (27.09.2022) 0.04 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 20.53 (27.09.2022) 2.19 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 12.12 (27.09.2022) 4.21 %
Gilead Sciences, Inc.
GILD 62.63 (27.09.2022) 0.47 %
GlaxoSmithKline plc
GSK 28.66 (27.09.2022) -0.56 %
GoodRx Holdings, Inc.
GDRX 5.03 (27.09.2022) -0.40 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 67.66 (28.09.2022) 1.84 %
Inovio Pharmaceuticals, Inc.
INO 1.84 (28.09.2022) 4.55 %
Johnson & Johnson
JNJ 166.36 (28.09.2022) 0.86 %
Medtronic plc.
MDT 82.59 (28.09.2022) 2.10 %
Merck & Co., Inc.
MRK 86.78 (28.09.2022) 1.10 %
Moderna, Inc.
MRNA 122.23 (27.09.2022) 2.12 %
Novartis AG
NVS 74.65 (27.09.2022) 0.05 %
Novavax, Inc.
NVAX 20.04 (27.09.2022) 6.20 %
ObsEva SA
OBSV 0.1402 (27.09.2022) -1.89 %
OrganiGram Holdings Inc.
OGI 0.9338 (28.09.2022) 4.35 %
Pfizer Inc.
PFE 44.09 (27.09.2022) 0.59 %
Regeneron Pharmaceuticals, Inc.
REGN 705.42 (28.09.2022) 1.50 %
Sanofi
SNY 37.22 (27.09.2022) -0.08 %
Schrodinger, Inc.
SDGR 24.12 (27.09.2022) 0.71 %
Senseonics Holdings, Inc.
SENS 1.33 (27.09.2022) 0.00 %
Sorrento Therapeutics, Inc.
SRNE 1.55 (27.09.2022) 2.65 %
Stryker Corp.
SYK 202.68 (27.09.2022) -0.29 %
Sundial Growers Inc.
SNDL 2.37 (28.09.2022) 5.80 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.96 (28.09.2022) 2.84 %
Thermo Fisher Scientific Inc.
TMO 508.66 (27.09.2022) -1.10 %
Tilray, Inc.
TLRY 3.01 (28.09.2022) 7.50 %
UnitedHealth Group, Inc.
UNH 508.37 (27.09.2022) 0.00 %
Veeva Systems Inc.
VEEV 164.72 (28.09.2022) 2.16 %
Zomedica Corp.
ZOM 0.2119 (27.09.2022) -1.21 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.8604 (28.09.2022) 1.18 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.